Table 3 Cytotoxic activities (IC50) of C13-methylene modified derivatives.
No. | IC50a (μM) | |
---|---|---|
PC-3 | HepG2 | |
1j | >40 | >40 |
1k | >40 | >40 |
1l | >40 | >40 |
1m | >40 | >40 |
1n | >40 | >40 |
1o | >40 | >40 |
1p | >40 | >40 |
1q | >40 | >40 |
1r | >50 | >50 |
1s | >50 | >50 |
No. | IC50a (μM) | |
---|---|---|
PC-3 | HepG2 | |
1j | >40 | >40 |
1k | >40 | >40 |
1l | >40 | >40 |
1m | >40 | >40 |
1n | >40 | >40 |
1o | >40 | >40 |
1p | >40 | >40 |
1q | >40 | >40 |
1r | >50 | >50 |
1s | >50 | >50 |